- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05921188
The Effect of Prior Learning on Word Learning
June 23, 2025 updated by: University of Arizona
Identification of Treatment Parameters That Maximize Language Treatment Efficacy for Children
The goal of this clinical trial is to compare two treatment conditions for late talking toddlers.
In 8 weeks of word learning treatment, toddlers will be taught words that sound more like the words they already know or sound less like the words they already know.
The investigators see which group learns more, to understand if choosing words that let children use the knowledge they already have helps with learning.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Late talking toddlers will be assigned to be in the More Familiar Sounds condition or the Less Familiar Sounds condition.
Both groups will receive 8 weeks of Vocabulary Acquisition and Usage for Late Talkers (VAULT) word learning treatment (2x/week for 30 minutes per session) using their words.
The investigators will compare learning within children (taught words v. control words that are not explicitly taught) to make sure the learning that is happening is due to the treatment and not just maturation.
The investigators will compare across groups to see if the group treated with More Familiar Sounding words learns more than the group treated with Less Familiar Sounding words.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85721
- University of Arizona
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Native English Speaking
- Pass pure tone hearing screening or medical report of normal hearing
- 2-3 Years of age at start of study
- MCDI expressive scales <10th percentile
Exclusion Criteria:
- Parental reports of other diagnoses
- Enrolled in concurrent treatment elsewhere
- Nonverbal IQ <75 as measured by the Bayley scales
- Parents unable to consistently bring child to treatment sessions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: More Familiar Sounds
Children in this condition will learn new words whose sounds are more like the sounds in the words the child already understands.
|
Children will receive an input-based word learning treatment that is designed based on principles of statistical learning.
|
|
Active Comparator: Less Familiar Sounds
Children in this condition will learn new words whose sounds are less like the sounds in the words the child already understands.
|
Children will receive an input-based word learning treatment that is designed based on principles of statistical learning.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment Effect Size
Time Frame: Change from baseline through treatment, which will average an 8-week time frame.
|
The investigators will count the number of spontaneous and probed productions of target and control words and calculate a treatment effect size (d).
|
Change from baseline through treatment, which will average an 8-week time frame.
|
|
Number/Rate of Words Learned
Time Frame: Change from Initial Evaluation through Follow-up, which will average a 6-month time frame.
|
The investigators will measure the number of words learned and the rate of words learned as reported by the parent on the MCDI starting prior to treatment and measured during, immediately following, and 4-6 weeks after the treatment.
|
Change from Initial Evaluation through Follow-up, which will average a 6-month time frame.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post Treatment Retention
Time Frame: Change from end of treatment to follow up, which will average 4-6 weeks.
|
The investigators will use probe data and parental report to determine how many of the words the child retained from treatment.
|
Change from end of treatment to follow up, which will average 4-6 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mary Alt, PhD, University of Arizona
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Actual)
June 6, 2025
Study Completion (Actual)
June 6, 2025
Study Registration Dates
First Submitted
June 14, 2023
First Submitted That Met QC Criteria
June 26, 2023
First Posted (Actual)
June 27, 2023
Study Record Updates
Last Update Posted (Actual)
June 27, 2025
Last Update Submitted That Met QC Criteria
June 23, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Late Talker Phase 4
- 2R01DC015642-06 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Language Development Disorders
-
Women and Infants Hospital of Rhode IslandCompletedAdolescent Behavior | Language Development | Development, Child | Language Delay
-
IRCCS Eugenio MedeaRecruitingLearning Disabilities | Development, Infant | Developmental Language Disorder | Development, LanguageItaly
-
IRCCS Eugenio MedeaEnrolling by invitationLanguage Development Disorders | Infant Development | Language Development | InterventionItaly
-
IRCCS Eugenio MedeaBasque Center on Cognition, Brain and Language (BCBL)RecruitingLanguage Development Disorders | Infant Development | Language Development | Infant Developmental AssessmentItaly
-
Université Catholique de LouvainNot yet recruitingUnderstanding the Predictive Factors and the Neurocognitive Basis of Developmental Language DisorderLanguage Development | Developmental Language DisordersBelgium
-
IRCCS Centro Neurolesi Bonino PulejoEnrolling by invitationDevelopment Language DisorderItaly
-
Purdue UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingLanguage Development | Developmental Language Disorder | Specific Language ImpairmentUnited States
-
Purdue UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedLanguage Development | Developmental Language Disorder | Specific Language ImpairmentUnited States
-
Purdue UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingDevelopmental Language Disorder and Language Impairment | Language Development | Specific Language ImpairmentUnited States
-
University of TorontoGeorgetown University; Children's Hospital Medical Center, Cincinnati; University... and other collaboratorsRecruitingLanguage Development | Developmental Language Disorder | Language DelayCanada
Clinical Trials on VAULT Phase 4
-
University of ArizonaNational Institute on Deafness and Other Communication Disorders (NIDCD)Recruiting
-
University of ArizonaNational Institute on Deafness and Other Communication Disorders (NIDCD)Not yet recruitingLanguage Development Disorders
-
PANAGOULA PAVLOUCompletedHydration | Anti-AgingGreece
-
Seoul National University Bundang HospitalKT CorporationCompletedMild Cognitive ImpairmentKorea, Republic of
-
Janssen Research & Development, LLCCompletedRelapsed or Refractory Hodgkin LymphomaFrance, Germany
-
University of CalgaryCanadian Institutes of Health Research (CIHR); The MSI FoundationRecruitingPelvic Organ ProlapseCanada
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyUnited Kingdom, Italy, Belgium, Netherlands, France
-
Hospices Civils de LyonCompletedHereditary Hemorrhagic TelangiectasiaFrance
-
Centre Georges Francois LeclercRecruiting
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)CompletedOpioid Abuse (Disorder)United States